These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1595646)

  • 1. Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori protease and lipases.
    Slomiany BL; Piotrowski J; Slomiany A
    Am J Gastroenterol; 1992 May; 87(5):595-9. PubMed ID: 1595646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulglycotide effect on the proteolytic and lipolytic activities of Helicobacter pylori toward gastric mucus.
    Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1994 Feb; 89(2):232-6. PubMed ID: 8304309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ebrotidine effect on the proteolytic and lipolytic activities of Helicobacter pylori.
    Slomiany BL; Piotrowski J; Mojtahed H; Slomiany A
    Gen Pharmacol; 1992 Mar; 23(2):203-6. PubMed ID: 1639232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipolytic activity of Campylobacter pylori: effect of colloidal bismuth subcitrate (De-Nol).
    Slomiany BL; Kasinathan C; Slomiany A
    Am J Gastroenterol; 1989 Oct; 84(10):1273-7. PubMed ID: 2801678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of growth factors to degradation by Helicobacter pylori protease: effect of ebrotidine and sucralfate.
    Slomiany BL; Piotrowski J; Slomiany A
    Biochem Mol Biol Int; 1996 Sep; 40(1):209-15. PubMed ID: 8886287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sucralfate counteracts the inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide.
    Slomiany A; Piotrowski J; Slomiany BL
    Scand J Gastroenterol Suppl; 1995; 210():77-81. PubMed ID: 8578214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosulfatase activity of H. pylori toward human gastric mucin: effect of sucralfate.
    Slomiany BL; Murty VL; Piotrowski J; Grabska M; Slomiany A
    Am J Gastroenterol; 1992 Sep; 87(9):1132-7. PubMed ID: 1381553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colloidal bismuth subcitrate (De-Nol) inhibits degradation of gastric mucus by Campylobacter pylori protease.
    Sarosiek J; Bilski J; Murty VL; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1989 May; 84(5):506-10. PubMed ID: 2470250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroprotective agents in mucosal defense against Helicobacter pylori.
    Slomiany BL; Murty VL; Piotrowski J; Slomiany A
    Gen Pharmacol; 1994 Sep; 25(5):833-41. PubMed ID: 7835626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipolytic activity of Campylobacter pylori: effect of sofalcone.
    Slomiany BL; Nishikawa H; Piotrowski J; Okazaki K; Slomiany A
    Digestion; 1989; 43(1-2):33-40. PubMed ID: 2806755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate.
    Slomiany BL; Piotrowski J; Slomiany A
    J Physiol Pharmacol; 2000 Jun; 51(2):179-92. PubMed ID: 10898092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of Helicobacter pylori pathogenesis: focus on mucus.
    Slomiany BL; Slomiany A
    J Clin Gastroenterol; 1992; 14 Suppl 1():S114-21. PubMed ID: 1378466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of sucralfate.
    Piotrowski J; Yamaki K; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1991 Dec; 86(12):1756-60. PubMed ID: 1835819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro inhibition of peptic degradation of porcine gastric mucus glycoprotein by sucralfate.
    Slomiany BL; Laszewicz W; Slomiany A
    Scand J Gastroenterol; 1985 Sep; 20(7):857-60. PubMed ID: 3931205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of Helicobacter pylori urease activity by sucralfate and sulglycotide.
    Slomiany BL; Piotrowski J; Slomiany A
    Biochem Mol Biol Int; 1997 Jun; 42(1):155-61. PubMed ID: 9192095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sucralfate on gastric mucosal inflammatory responses induced by Helicobacter pylori lipopolysaccharide.
    Slomiany BL; Piotrowski J; Slomiany A
    Scand J Gastroenterol; 1998 Sep; 33(9):916-22. PubMed ID: 9759945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori lipopolysaccharide inhibition of gastric somatostatin receptor: effect of sucralfate.
    Piotrowski J; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1997 Jul; 42(3):545-51. PubMed ID: 9247712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sucralfate on vacuolating cytotoxin activity and adherence of Helicobacter pylori to human gastric epithelial cells.
    Smoot DT; Earlington MH; Abebe E; Desbordes BC; Murigande C; Naab T
    J Assoc Acad Minor Phys; 1996; 7(4):88-92. PubMed ID: 8936934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakdown of gastric mucus in presence of Helicobacter pylori.
    Sidebotham RL; Batten JJ; Karim QN; Spencer J; Baron JH
    J Clin Pathol; 1991 Jan; 44(1):52-7. PubMed ID: 1997534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.